Membranous type matrix metalloproteinase 16 induces human prostate cancer metastasis.
Matrix metalloproteinases (MMPs) are a family of proteolytic enzymes, which perform a crucial role in the metastatic spread of cancer. MMP2 and MMP9 are important cancer-associated MMPs in the invasion and metastasis of the majority of carcinomas. As a new member of the membrane-type MMPs, the function of MMP16 associated with invasion and metastasis of cancer remains unclear. In the present study, MMP16 expression in prostate cancer (PCa) tissues and cells was examined, and the high expression of MMP16 was revealed to be associated with advanced prostate tumor stage and PCa cell metastasis. The membrane localization of MMP16 is required for its function. To the best of our knowledge, the present study is the first to demonstrate that MMP16 is associated with advanced prostate tumor stage. As an important mediator of PCa cell metastasis, the membrane localization of MMP16 is required, and MMP16 may be an ideal target candidate for preventing PCa cell metastasis.
['Jiang|Chunwa|C|', 'Wang|Juanjing|J|', 'Dong|Chen|C|', 'Wei|Wei|W|', 'Li|Jiang|J|', 'Li|Xiaomeng|X|']
matrix metalloproteinase 16 prostate cancer metastasis invasion prostate tumor stage transmembrane location